For example, when TNF-α inhibitors were used to treat patients with chronic inflammatory diseases, such as rheumatoid arthritis and Crohn’s disease, it reflected in serious cardiovascular complications with adverse outcomes, although the incidence was very rare. This evidence concerns the gene TNF and rheumatoid arthritis.